Healthcare provider profile · identity verified

Rajendrakumar I Patel, M.D.

Internal Medicine · WEBB CITY, MO · NPI 1578517421

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	528	85
Amlodipine Besylate	Amlodipine Besylate	421	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	407	44
Levothyroxine Sodium	Levothyroxine Sodium	386	35
Pantoprazole Sodium	Pantoprazole Sodium	365	32
Gabapentin	Gabapentin	308	32
Quetiapine Fumarate	Quetiapine Fumarate	264	18
Irbesartan	Irbesartan	246	28
Alprazolam	Alprazolam	244	26
Metformin Hcl	Metformin Hcl	238	24
Potassium Chloride	Potassium Chloride	222	26
Sertraline Hcl	Sertraline Hcl	222	22
Hydrochlorothiazide	Hydrochlorothiazide	221	25
Omeprazole	Omeprazole	211	32
Furosemide	Furosemide	210	22
Lisinopril	Lisinopril	193	24
Trazodone Hcl	Trazodone Hcl	192	17
Rosuvastatin Calcium	Rosuvastatin Calcium	174	suppressed
Donepezil Hcl	Donepezil Hcl	170	11
Famotidine	Famotidine	166	12
Clopidogrel	Clopidogrel Bisulfate	147	13
Eliquis	Apixaban	145	14
Losartan Potassium	Losartan Potassium	140	14
Lorazepam	Lorazepam	126	15
Duloxetine Hcl	Duloxetine Hcl	107	suppressed
Mirtazapine	Mirtazapine	106	suppressed
Oxycodone Hcl	Oxycodone Hcl	106	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	102	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	102	11
Baclofen	Baclofen	97	suppressed
Ozempic	Semaglutide	95	15
Memantine Hcl	Memantine Hcl	88	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	87	suppressed
Ezetimibe	Ezetimibe	86	suppressed
Metoprolol Succinate	Metoprolol Succinate	85	20
Levetiracetam	Levetiracetam	83	suppressed
Meloxicam	Meloxicam	82	suppressed
Carvedilol	Carvedilol	74	14
Allopurinol	Allopurinol	71	suppressed
Citalopram Hbr	Citalopram Hydrobromide	70	11
Paroxetine Hcl	Paroxetine Hcl	70	suppressed
Metformin Hcl Er	Metformin Hcl	69	13
Aripiprazole	Aripiprazole	68	suppressed
Myrbetriq	Mirabegron	68	suppressed
Spironolactone	Spironolactone	67	suppressed
Alendronate Sodium	Alendronate Sodium	66	suppressed
Divalproex Sodium	Divalproex Sodium	66	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	66	suppressed
Tizanidine Hcl	Tizanidine Hcl	64	suppressed
Pregabalin	Pregabalin	61	suppressed
Divalproex Sodium Er	Divalproex Sodium	59	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	58	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	57	suppressed
Hydralazine Hcl	Hydralazine Hcl	57	suppressed
Atenolol	Atenolol	56	suppressed
Fluticasone Propionate	Fluticasone Propionate	54	11
Naproxen	Naproxen	50	suppressed
Nifedipine Er	Nifedipine	49	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	suppressed
Estradiol	Estradiol	46	suppressed
Risperidone	Risperidone	45	suppressed
Trulicity	Dulaglutide	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Topiramate	Topiramate	39	suppressed
Cephalexin	Cephalexin	38	21
Jardiance	Empagliflozin	36	suppressed
Ibuprofen	Ibuprofen	35	suppressed
Temazepam	Temazepam	35	suppressed
Loperamide	Loperamide Hcl	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Prednisone	Prednisone	31	15
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Anastrozole	Anastrozole	26	suppressed
Cimetidine	Cimetidine	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Ranolazine Er	Ranolazine	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Simvastatin	Simvastatin	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Clozapine	Clozapine	23	suppressed
Colestipol Hcl	Colestipol Hcl	23	suppressed
Diazepam	Diazepam	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Novolin R Flexpen	Insulin Regular, Human	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	21	suppressed
Timolol Maleate	Timolol Maleate	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Glimepiride	Glimepiride	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Cartia Xt	Diltiazem Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Nystatin	Nystatin	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Finasteride	Finasteride	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Asenapine Maleate	Asenapine Maleate	14	suppressed
Emgality Pen	Galcanezumab-Gnlm	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	14	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Belsomra	Suvorexant	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Belbuca	Buprenorphine Hcl	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Soma	Carisoprodol	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error